Global oral health innovator GC Corporation, along with U.S. affiliate GC America, faced allegations of patent infringement brought by a major competitor. Our firm secured an initial determination of “no violation” from the International Trade Commission’s chief administrative law judge.
After a full trial on merits, the verdict was upheld by the full commission. This win ensures that the GC Initial LiSi Press ingot technology for dentists and dental laboratories remains available in the U.S. without disruption.
